Skip to main content
All lobbying filings

VENN STRATEGIES

VENN STRATEGIES filed a Q1 report for PACIRA PHARMACEUTICALS INC. on April 15, 2026, reporting $90,000 in lobbying income.

Lobbying for PACIRA PHARMACEUTICALS INC. · Pharmaceutical company

All filings by VENN STRATEGIES · Everything PACIRA PHARMACEUTICALS INC. has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 15, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Improving access to non-opioid approaches to pain management.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem